Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
KURA
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -9.9%
KURA
Kura Oncology, Inc.
☁️ News word cloud
Top words across the last 50 articles for this ticker.
oncology
nasdaq
announced
clinical
2024
ziftomenib
after
results
inducement
treatment
cancer
today
2023
npm1
financial
trial
leukemia
data
mutant
acute
StonvexStonvexStonvexStonvex